Evogene Ltd. EVGN

Set alert

Price alert · EVGN

All alert types
0.37 USD -0.01 -1.45%

At close · Oct 30

0.37 0.00 -0.40%

After hours · Oct 30, 4:00 PM ET

Bid
0.36 × 1
Ask
0.38 × 6
0.3653 Day range 0.3799
0.36 52-week range 1.26
YTD
-65.95%
1 year
-69.54%
Open
0.3775
Prev close
0.3801
Mkt cap
5.09M
Vol
14.77K
Avg vol
1.42M
EPS
-1.53
P/E
0.00
Div yield
0.00%
More statistics
Low
0.3653
High
0.3799
Forward P/E
-0.39
Beta
1.08
Short ratio
0.04
Inst. own
11.12%
Dividend
0.00
Ex-div date
50-d avg
1.87
200-d avg
4.76
1y target
8.13

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for EVGN has not been loaded yet. Try again in a moment.

Discussion (17)

Sign in to join the discussion

Oleksandr Naumov EVGN 4 years ago #2

Looks like $FIODOR and $TEO are my best friends here :)
Have a great day
Hope tomorrow will bring us a great news

Oleksandr Naumov EVGN 4 years ago #5

No volume. Will stay $0.75 - $1.00 till investors come back. Then $2 -$5. Then $7+

Oleksandr Naumov EVGN 4 years ago #6

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the first quarter of 2022 on Thursday, May 26, 2022. Dr. Elran Haber, Chief Executive Officer of Evogene's subsidiary, Biomica Ltd., will be joining the conference call to discuss Biomica's recent activity.